Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder in children but may also occur in adults. About two-thirds of children diagnosed with ADHD experience symptoms in adulthood.
Symptoms of ADHD are organized into two major clusters:
Inattention: Forgetfulness, disorganization, difficulty sustaining attention in tasks or play, frequent misplacing items, easily distracted, failure to finish tasks.
Hyperactivity/Impulsivity: Restlessness, difficulty remaining seated, incessant talking, fidgeting, impatience, blurting out answers, difficulty waiting one's turn, and interrupting or intruding on others.
Some individuals experience only inattentive symptoms or only hyperactivity/impulsivity symptoms while others experience both (i.e., combined type).
Males are more likely to be diagnosed in childhood or adolescence because males display more hyperactive symptoms than females and therefore are more likely to be referred for evaluation. Females usually experience more inattentive symptoms and, unfortunately, this means they are often not diagnosed until later in life.
The diagnosis of ADHD requires a comprehensive evaluation by a clinician experienced in ADHD. A comprehensive evaluation usually includes a combination of the following:
Clinical interviews.
Rating scales and questionnaires.
Review of past academic and work records.
Rule out other possible causes of symptoms.
Observations reported by family, friends, teachers, or employers.
The Diagnostic and Statistical Manual of Mental Disorders (DSM) is published by the American Psychiatric Association and is used by clinicians in the U.S. (and to some extent, globally) as a standard classification of mental disorders. It contains descriptions, symptoms, and other criteria necessary for diagnosing mental health disorders. Over the years, there have been several versions of the DSM, with the DSM-5-TR being the most recent edition published in 2022.
To be diagnosed with ADHD, an individual must meet the following criteria:
A. A persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development, as characterized by (1) and/or (2):
(1) Inattention: Six (or more) of the following symptoms have persisted for at least six months to a degree that is inconsistent with developmental level and that negatively impacts directly on social and academic/occupational activities:
Often fails to give close attention to details or makes careless mistakes.
Often has difficulty sustaining attention in tasks or play activities.
Often does not seem to listen when spoken to directly.
Often does not follow through on instructions and fails to finish schoolwork, chores, or duties in the workplace.
Often has difficulty organizing tasks and activities.
Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort.
Often loses things necessary for tasks or activities.
Is often easily distracted by extraneous stimuli.
Is often forgetful in daily activities.
(2) Hyperactivity and Impulsivity: Six (or more) of the following symptoms have persisted for at least six months to a degree that is inconsistent with developmental level and that negatively impacts directly on social and academic/occupational activities:
Often fidgets with or taps hands or feet or squirms in seat.
Often leaves seat in situations when remaining seated is expected.
Often runs or climbs in situations where it is inappropriate. (Note: In adolescents or adults, may be limited to feeling restless.)
Often unable to play or engage in leisure activities quietly.
Is often "on the go," acting as if "driven by a motor."
Often talks excessively.
Often blurts out an answer before a question has been completed.
Often has difficulty waiting his or her turn.
Often interrupts or intrudes on others.
B. Several inattentive or hyperactivity-impulsivity symptoms were present before age 12 years.
C. Several inattentive or hyperactivity-impulsivity symptoms are present in two or more settings (e.g., at home, school, or work; with friends or relatives; in other activities).
D. There is clear evidence that the symptoms interfere with, or reduce the quality of, social, academic, or occupational functioning.
E. The symptoms do not occur exclusively during the course of schizophrenia or another psychotic disorder and are not better explained by another mental disorder.
The DSM-5 also specifies the following subtypes of ADHD based on the predominant symptom pattern for the past six months:
Combined Presentation: If both Criteria A1 (Inattention) and A2 (Hyperactivity-Impulsivity) are met for the past six months.
Predominantly Inattentive Presentation: If Criterion A1 (Inattention) is met but Criterion A2 (Hyperactivity-Impulsivity) is not met for the past six months.
Predominantly Hyperactive-Impulsive Presentation: If Criterion A2 (Hyperactivity-Impulsivity) is met and Criterion A1 (Inattention) is not met for the past six months.
Inattention and hyperactivity/impulsivity usually present differently in adults.
Inattention in adults often manifests as chronic boredom, indecisiveness, mind wandering/daydreaming, procrastinating, disorganization, and distractibility.
Hyperactivity/Impulsivity in adults often manifests as inner restlessness, talkativeness, excessive fidgeting, engagement in high-risk activities, general impatience, talking without thinking, problems maintaining employment, difficulty maintaining relationships, attention seeking behavior, and self-medicating with drugs and alcohol.
Adults with ADHD often report rapid mood swings, difficulties dealing with stressful situations, persistent irritability, emotional excitability (e.g., anger over minor things), relationship problems (e.g., short-lived, divorce), and low frustration tolerance.
The symptoms of ADHD present slightly differently in males and females. A list of differences is provided in the table below.
Adults with ADHD often experience the following:
Occupational challenges: Lower job performance, frequent job changes, unemployment.
Relationship difficulties: Higher rates of separation and divorce, parenting challenges.
Co-existing conditions: Increased risk of anxiety, depression, substance use disorders, and other comorbid conditions.
Substance Abuse: Numerous studies have shown that ADHD and substance abuse have a high comorbidity. That is, individuals with ADHD are at high risk of substance abuse in adulthood. This risk is significantly elevated if symptoms are left untreated. When ADHD symptoms are treated appropriately, the risk of substance abuse declines dramatically.
Academic issues: Difficulty in higher education settings due to challenges with focus, organization, and task completion.
Driving issues: More traffic violations, accidents, and revoked licenses.
Studies vary, but it's estimated that 2.5-5% of adults have ADHD. Many remain undiagnosed.
Adult ADHD can be under-recognized for a variety of reasons:
The hyperactivity component may decrease with age.
Symptoms can be mistaken for other disorders or life challenges.
There's a myth that children "outgrow" ADHD.
Differentiating ADHD from Bipolar Disorder can be difficult because many symptoms overlap and both disorders often co-occur (that is, many patients have both ADHD and Bipolar Disorder). Below is a table that helps differentiate the two.
Attention describes the process of determining the importance of various stimuli and selecting the one that's most relevant to the task at hand. Attention is an important component of our consciousness.
Although neural networks throughout the entire brain contribute to most brain functions, there are some areas of the brain that may play a greater role in attentiveness. These areas include the prefrontal cortex (which is part of the frontal lobe), parietal cortex, and the cingulate cortex.
Dopamine and norepinephrine are two very important brain chemicals involved in attention, movement, and impulse control.
These two chemicals work together to "filter out" irrelevant stimuli while enhancing the relevant stimuli. In individuals with ADHD, these two chemicals appear to be imbalanced or "out of tune." By enhancing these brain chemicals with medications and therapy we can improve symptoms dramatically.
Changes in the prefrontal cortex (PFC) and an area called the striatum are the most common abnormal brain findings reported for ADHD.
Judith Rapoport’s National Institute of Mental Health (NIMH) neuroimaging studies have revealed interesting findings in children with ADHD.
Children with ADHD, on average, have smaller brain volumes by about 5% and also have smaller cerebellums (the little brain in the back of the brain). Importantly, the trajectory of brain volumes did not change as the children aged, nor was it affected by the use of stimulant medication.
When comparing brain activity in children with and without ADHD, there was significantly greater activity in the parietal and frontal lobes of children without ADHD during an attention task. This tells us that decreased activity in the frontal and parietal lobes may partially explain inattentiveness. That is, these brain areas aren't activated enough during attention-requiring tasks.
Medications remain the primary treatment for ADHD symptoms. Medications primarily target symptoms of inattention, mood reactivity, restlessness, ruminative-type anxiety, scattered thinking, and procrastination. Through a variety of mechanisms, medications help with filtering out extraneous external and internal sensory stimuli that are distracting and counterproductive in patients with hypersensitive nervous systems. Below is an overview of medications used to treat ADHD symptoms.
Psychostimulants (Amphetamines and Methylphenidates)
This is the most common type of medication used for ADHD. These drugs work by increasing the levels of certain chemicals such as norepinephrine, dopamine, and serotonin in the brain. Psychostimulant medications such as amphetamines (Adderall, Dexedrine, Vyvanse) and methylphenidates (Ritalin, Concerta, Focalin) are first line treatments for attention deficit hyperactivity disorder but are also helpful to alleviate symptoms of fatigue, low motivation, and concentration problems in patients with other psychiatric conditions.
Modafinil (Provigil) and Armodafinil (Nuvigil)
While not classic stimulants, these medications primarily target histamine in the brain and are used to treat fatigue associated with narcolepsy and sleep apnea but are also used successfully in individuals with low motivation and attentional problems. These medications are less habit forming than dopaminergic stimulants like amphetamines and methylphenidates.
Nonstimulants (Atomoxetine, Clonidine, Guanfacine, and Bupropion)
These are usually considered when stimulants haven’t worked or have caused unacceptable side effects. Atomoxetine (Strattera) is one such medication that increases the levels of norepinephrine in the brain, which can help with symptoms of ADHD. Another is guanfacine (Intuniv) and clonidine (Catapres) which are thought to modulate norepinephrine receptors in the prefrontal cortex, a part of the brain associated with attention and impulse control. Although not first-line treatment, certain antidepressants may be used off-label for ADHD. These include norepinephrine-dopamine reuptake inhibitors (NDRIs) like bupropion (Wellbutrin) and norepinephrine reuptake inhibitors like atomoxetine (Strattera).
Cognitive Behavioral Therapy (CBT) focuses on teaching skills to manage symptoms and cope with the challenges of everyday life. Neurofeedback/Biofeedback has been shown to be helpful in improving attention and concentration in individuals with ADHD. Regular exercise, sleep hygiene, a routine schedule, a structured environment, and a balanced diet can be beneficial.
With appropriate treatment and strategies in place, many adults with ADHD lead successful and fulfilling lives. However, untreated ADHD can have significant negative impacts on various aspects of life.